Rocket Pharmaceuticals (RCKT)

Rocket Pharmaceuticals, Ltd. • Rocket Foundation, Inc. • Spacecraft Seven, LLC • Zebrafish Merger Sub II, LLC • Rocket Pharmaceutical, Inc. • Rocket Pharmaceuticals, B.V. • Rocket Pharmaceuticals, GmbH • Rocket Pharmaceuticals UK, Ltd. • Rocket Pharmaceuticals Spain, S.L. ...

RCKT stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$37.33

Low target

$29.00

High target

$44.00

Latest filings (excl ownership)

View all

8-K

Departure of Directors or Certain Officers

27 Jan 25

8-K

Entry into a Material Definitive Agreement

12 Dec 24

424B5

Prospectus supplement for primary offering

12 Dec 24

424B5

Prospectus supplement for primary offering

10 Dec 24

8-K

Departure of Directors or Certain Officers

5 Dec 24

8-K

Regulation FD Disclosure

7 Nov 24

Rocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Progress

7 Nov 24

8-K

Departure of Directors or Certain Officers

11 Sep 24

S-3ASR

Automatic shelf registration

16 Aug 24

Transcripts

RCKT

Earnings call transcript

2021 Q2

10 Aug 21

Latest ownership filings

View all

Jonathan David Schwartz

WELLINGTON MANAGEMENT GROUP LLP

Notice of proposed sale of securities

31 Jan 25

Financial summary

Financial statements Chart RCKT financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	66.96 mm	66.96 mm	66.96 mm	66.96 mm	66.96 mm	66.96 mm
Cash burn (monthly)	(no burn)	13.34 mm	23.14 mm	22.82 mm	17.37 mm	16.01 mm
Cash used (since last report)	n/a	60.48 mm	104.92 mm	103.44 mm	78.74 mm	72.59 mm
Cash remaining	n/a	6.48 mm	-37.96 mm	-36.48 mm	-11.78 mm	-5.63 mm
Runway (months of cash)	n/a	0.5	-1.6	-1.6	-0.7	-0.4

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

RCKT institutional ownership history Ownership history

89.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	192	179	+7.3%
Opened positions	35	19	+84.2%
Closed positions	22	39	-43.6%
Increased positions	64	71	-9.9%
Reduced positions	53	52	+1.9%

13F shares	Current	Prev Q	Change
Total value	1.63 tn	1.88 tn	-13.2%
Total shares	95.08 mm	93.72 mm	+1.5%
Total puts	70.30 k	111.00 k	-36.7%
Total calls	211.17 k	114.40 k	+84.6%
Total put/call ratio	0.3	1.0	-65.7%

Largest owners	Shares	Value	Change
RTW Investments	17.69 mm	$326.69 bn	0.0%
Wellington Management	11.24 mm	$207.64 bn	+22.8%
BlackRock	6.37 mm	$117.67 bn	NEW
Vanguard	5.54 mm	$102.27 bn	-4.7%
Westfield Capital Management	4.49 mm	$83.00 bn	+3.8%
Maverick Capital	4.12 mm	$76.07 bn	+4.8%
T. Rowe Price	3.21 mm	$59.25 mm	+1.2%
STT State Street	3.10 mm	$57.29 bn	+11.6%
Tang Capital Partners	2.53 mm	$0.00	0.0%
Citadel Advisors	2.15 mm	$39.68 bn	-23.8%

Largest transactions	Shares	Bought/sold	Change
BlackRock	6.37 mm	+6.37 mm	NEW
BLK BlackRock	0.00	-6.19 mm	EXIT
Wellington Management	11.24 mm	+2.09 mm	+22.8%
Millennium Management	1.20 mm	+1.10 mm	+1041.7%
MPM Oncology Impact Management	1.07 mm	+1.07 mm	NEW
JHG Janus Henderson	1.90 mm	-1.02 mm	-35.0%
BAC Bank of America	406.16 k	-831.89 k	-67.2%
Citadel Advisors	2.15 mm	-669.98 k	-23.8%
EcoR1 Capital	0.00	-508.39 k	EXIT
Avidity Partners Management	749.00 k	-351.00 k	-31.9%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

RCKT insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
11 Feb 25	Martin Wilson	Common Stock	Grant	Acquire A	No	No	0	90,358	0.00	153,918
11 Feb 25	Martin Wilson	Stock Option Common Stock	Grant	Acquire A	No	No	9.88	134,642	1.33 mm	134,642
11 Feb 25	Shah Gaurav	Common Stock	Grant	Acquire A	No	No	0	81,655	0.00	788,983
11 Feb 25	Shah Gaurav	Stock Option Common Stock	Grant	Acquire A	No	No	9.88	243,345	2.40 mm	243,345
11 Feb 25	Jonathan David Schwartz	Common Stock	Grant	Acquire A	No	No	0	80,318	0.00	252,731
11 Feb 25	Jonathan David Schwartz	Stock Option Common Stock	Grant	Acquire A	No	No	9.88	119,682	1.18 mm	119,682
11 Feb 25	Patel Kinnari	Common Stock	Grant	Acquire A	No	No	0	57,786	0.00	450,181
11 Feb 25	Patel Kinnari	Stock Option Common Stock	Grant	Acquire A	No	No	9.88	172,214	1.70 mm	172,214
11 Feb 25	Aaron Ondrey	Common Stock	Grant	Acquire A	No	No	0	90,358	0.00	137,139
11 Feb 25	Aaron Ondrey	Stock Option Common Stock	Grant	Acquire A	No	No	9.88	134,642	1.33 mm	134,642